Take stock of four hot spots in this week's Medical News

This week's hot news in the pharmaceutical industry is not abating The Xiaobian of yaozhi.com sums up and sorts the news on four aspects: drug price, pharmaceutical enterprises, internet medical treatment and medical reform policy, so that you can know the latest news of this week's medicine in a minute Drug price: Director of the price department of the national development and Reform Commission: to liberalize most of the drug price reform has always been a breakthrough in comprehensively deepening the reform and the key to promoting the reform in key areas Xu Kunlin, director of the price department of the national development and Reform Commission, said that in the next step, the state will liberalize the prices of many competitive goods and services, including the vast majority of drugs, railway transportation fees, some postal service fees, and some professional services Independent pricing of original research drug: unreasonable recently, the original research drug with independent pricing has become a big issue in the new round of drug bidding! The original research drug mainly refers to the imported drug that has passed the patent protection period In the government pricing method of drugs in China, the original research drugs are classified as a separate category, which can be priced separately and protected specially In response, industry insiders have said: drug prices are related to the people's livelihood, our medical insurance should not pay for high-priced original research drugs, and the elimination of independent pricing of original research drugs is a necessary way to achieve fair and just drug bidding The defendant of the national development and Reform Commission won the bid because the drug price was 20 times higher than that of the same kind Recently, we saw from the results of the new round of centralized drug procurement and network hanging in Hunan Province that only one ordinary azithromycin tablet of 500mg specification won the bid of priva Croatia Co., Ltd., with a bid price of 16.550 yuan per tablet The comparison found that the price was 20 times higher than that of the same kind of drugs Known as "the Xiake in the industry", Guangzhou berserro Pharmaceutical Co., Ltd was not satisfied with such pricing, and sued the national development and Reform Commission to the first intermediate people's Court of Beijing Pharmaceutical companies: Novartis has won the top 25 in global prescription drug sales in 2014 Recently, global data, a well-known global market research company, released the list of top 25 pharmaceutical giants in global prescription drug sales in 2014, which is based on the sales data of prescription drugs (including generic drugs) of major pharmaceutical companies in the global drug market In 2014, Novartis, the Swiss pharmaceutical giant, surpassed Pfizer, the US pharmaceutical giant that has been No 1 in the past 10 years, to the top of the list Onlookers: Squibb has laid off thousands of employees Due to the large-scale business transformation period, Bristol Myers Squibb Company of the United States has significantly reduced its medical representatives in China since 2014, with a total number of nearly 1000 people leaving, involving many departments such as the cancer business department, the cardiovascular business department, the OTC business department, etc However, due to improper handling, the staff rebounded strongly, and now it is in court with hundreds of former employees As the general trend, the competition for Foxconn to enter the consumer electronics manufacturing industry in the medical market is becoming increasingly fierce Foxconn hopes to find new growth engines and new customers This time, Foxconn mainly focuses on radiotherapy equipment Foxconn executives say that in different countries, medical devices usually take more than a year to obtain the necessary regulatory clearance, so it's more challenging than assembling consumer electronics China Resources Shuanghe plans to purchase 3.7 billion yuan from China Resources SECCO China Resources Shuanghe recently issued an evening announcement It plans to purchase 100% of China Resources SECCO's equity held by Beijing Pharmaceutical Group through a combination of non-public issuance of shares and cash payment, with a transaction price of 3.701 billion yuan The company's shares resumed trading on April 20 Great event! Xinyitang's acquisition of Hainan Guang'an Tang with a total capital of 323 million yuan According to the announcement issued by Yunnan Hongxiang xinyitang Pharmaceutical (Group) Co., Ltd on April 22, because of its business positioning and development planning, xinyitang plans to use its own funds, 3.22 million yuan to purchase 100% equity of Hainan United Guang'an Tang Pharmaceutical supermarket chain operation Co., Ltd held by Hainan Guang'an Tang Pharmaceutical supermarket group Co., Ltd People's pharmacy successfully listed: market value 6.3 billion, the amount of fundraising is more than one center, Yifeng! On the morning of April 23, the common people drugstore chain Co., Ltd was officially listed and traded on the Shanghai Stock Exchange, with the stock code of 603883 and the stock abbreviation of "common people", marking the realization of its dream of listing since 2008, which also changed the concept shares of the direct chain drugstores in the A-share market from the previous two wheel drive to the three arrow drive Internet medicine: to realize "health cloud", medical records of more than 30 hospitals in Beijing will be "interconnected" In order to realize the "health cloud" in the capital, Beijing Municipal Commission of health and family planning recently announced that this year, more than 30 hospitals and 8 districts and counties will pilot the interconnection of electronic medical records, so as to realize the sharing of laboratory, image, diagnosis and other information of patients' visits, so that when patients go to the hospital for medical treatment, doctors can directly transfer out patients' previous medical records and examination results Medical big data is on sale! In the first big data exchange in China recently, Guiyang big data exchange, the first big data exchange in China, was officially listed for operation and completed the first batch of big data transactions Chen Gang, member of the Standing Committee of Guizhou provincial Party committee and Secretary of the municipal Party committee, attended the trading ceremony and conference, launched the first batch of transactions of Guiyang big data exchange and Guizhou tongtsm platform, and awarded the big data dealers (Guiyang) alliance For the first batch of data transactions completed this time, the seller is Shenzhen Tencent computer system Co., Ltd., Guangdong Digital Guangdong Research Institute, and the buyer is JD cloud platform and Zhongjin Data System Co., Ltd Recently, the national health and Family Planning Commission said that in addition to telemedicine carried out by qualified hospitals, treatment involving medical diagnosis on the Internet is not allowed Then, is internet medical treatment illegal? Chen Qiulin, deputy researcher of the Institute of population and labor economy of the Academy of Social Sciences, responded: "some consultation on the Internet is not involved in medical diagnosis and treatment, and no medical disputes will occur; or it can be clear about the subject of disputes, such as telemedicine carried out by qualified hospitals, which should be allowed However, there may be medical disputes, and the main body of the dispute can not be clearly identified, which is illegal in the absence of clear provisions of the law " Medical reform policy: Gansu medical reform: to ensure the supply of drugs in short supply In order to ensure the shortage of drugs for clinical necessity and first aid, on April 21, Gansu Provincial Health and Family Planning Commission issued a civilized decision The health and family planning administrative departments and medical institutions at all levels should include the number of short and thin drugs produced by enterprises directly linked to the Internet into the examination of selecting and distributing enterprises, and take it as an important basis for their selection and withdrawal Director of Anhui health and Family Planning Commission: it is one of the important measures of Anhui comprehensive medical reform pilot that drug recruitment policy is boycotted by interest groups As this measure will change the inherent interest pattern of drug distribution enterprises, it has aroused strong repercussions after its promulgation, especially the strong resistance of some small and medium-sized drug distribution enterprises Some people go to the provincial government for petitions, and some media have questioned and criticized reports when the reform measures have not been implemented On April 15-17, Ma Xiaowei, deputy director of the national health and Family Planning Commission, led a team to investigate and supervise the work of medical reform in Changchun, Jilin Province Ma Xiaowei said that the next step of the comprehensive medical reform idea is to vigorously promote the reform of public hospitals, improve the compensation mechanism of public hospitals, straighten out the relationship between medical services and prices, accelerate the establishment of modern hospital management system, deepen the reform of personnel compensation system, and fully mobilize the enthusiasm of medical personnel The revised draft of the advertising law strictly limits illegal advertising on drugs and health products The revised draft of the advertising law, which was submitted to the 14th session of the Standing Committee of the 12th National People's Congress for deliberation on the 20th, has been reviewed three times It has made more strict restrictions on the advertising of drugs and health food, the advertising behavior of health programs, and the advertising activities It is clearly stipulated that those who endorse false advertisements may have a three-year "ban period", illegally advertise, and medical institutions may have their licenses revoked Document issued by the State Council: on April 21, the general office of the State Council issued the key points of 2015 government information disclosure, requiring the government to strengthen the information disclosure According to the key points of work, relevant departments should disclose the information in the field of medical and health care, promote various medical institutions to improve the information disclosure catalogue, and comprehensively disclose the information of medical services, prices, charges, etc At the same time, we will make sure that information about infectious diseases and major public health emergencies is made public It is no longer difficult for Lanzhou to issue the record of referral medical institutions and transfer to other places for medical treatment Recently, the regulations on the management of remote medical treatment of urban basic medical insurance in Lanzhou city was officially issued, which further regulated the application process, medical expense audit and settlement, management of referral medical institutions, management of medical personnel, and dispute handling of urban medical insurance insured personnel during the period of relocation, transfer to other places for medical treatment, business trip to visit relatives, etc Among them, increase the channels for abnormal approval of medical expenses in different places, and if the transfer formalities are not handled in time due to the critical condition and other special circumstances, the supplementary procedures shall be carried out within 20 days after the transfer; For the medical expenses in different places that do not belong to the scope of application, if it is really due to special circumstances, after being examined and approved by the municipal medical insurance agency, the medical expenses that meet the scope of medical insurance payment shall be paid by the individual 50%, and the rest shall be reimbursed according to the relevant standards and proportions The intellectual property rights of the above articles belong to yaozhi.com If you need to reprint, please indicate the source and the link of this article.